This is consistent with prior research which showed that X- linked agammaglobulinemia (XLA) patients have significantly higher soluble BAFF concentrations compared to healthy controls (p < 0.001)14. The gene discussed is TNFSF13B; the disease is isolated agammaglobulinemia.